Individual results vary based on genetics, lifestyle, and dose tolerability, but most patients experience measurable weight reduction within 8 weeks
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
Results from 6 double-blind randomized, controlled trials suggest supplementing with zinc can improve mood
GLP-1 medications can slow stomach emptying , particularly early after meals
Yuliasih, Y., Rahmawati, L
Thats how committed we are to your recovery